LB Pharmaceuticals
Andrew Vaino, Ph.D. has been the Chief Scientific Officer since 2015. Dr. Vaino was Senior Vice President of Research and Development at Retrophin, where he co-invented the company’s RE-024 product for the treatment of PKAN. Dr. Vaino received his Ph.D. in chemistry from Queen’s University and his MBA from the University of California, Irvine.
This person is not in any teams
This person is not in any offices